JP2007516173A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007516173A5 JP2007516173A5 JP2006517466A JP2006517466A JP2007516173A5 JP 2007516173 A5 JP2007516173 A5 JP 2007516173A5 JP 2006517466 A JP2006517466 A JP 2006517466A JP 2006517466 A JP2006517466 A JP 2006517466A JP 2007516173 A5 JP2007516173 A5 JP 2007516173A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- indazol
- oxo
- tetrahydro
- pyrimidinecarboxamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 14
- 125000001309 chloro group Chemical group Cl* 0.000 claims 11
- 150000003839 salts Chemical class 0.000 claims 10
- 239000012453 solvate Substances 0.000 claims 10
- 150000001875 compounds Chemical class 0.000 claims 8
- -1 methoxy, ethoxy Chemical group 0.000 claims 8
- WOOLOAFADUQHNQ-UHFFFAOYSA-N 4-(3,5-difluorophenyl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxylic acid Chemical compound N1C(=O)NC(C)=C(C(O)=O)C1C1=CC(F)=CC(F)=C1 WOOLOAFADUQHNQ-UHFFFAOYSA-N 0.000 claims 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 3
- MODPFIYPSWMRNZ-UHFFFAOYSA-N 3-ethyl-6-(4-fluorophenyl)-n-(1h-indazol-5-yl)-4-methyl-2-oxo-1,6-dihydropyrimidine-5-carboxamide Chemical compound C=1C=C2NN=CC2=CC=1NC(=O)C1=C(C)N(CC)C(=O)NC1C1=CC=C(F)C=C1 MODPFIYPSWMRNZ-UHFFFAOYSA-N 0.000 claims 2
- VRJZWJDDURABEQ-UHFFFAOYSA-N 4-[4-[4-(dimethylamino)phenyl]phenyl]-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(C2C(=C(C)NC(=O)N2)C(=O)NC=2C=C3C=NNC3=CC=2)C=C1 VRJZWJDDURABEQ-UHFFFAOYSA-N 0.000 claims 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 2
- QPJVMBTYPHYUOC-UHFFFAOYSA-N Methyl benzoate Natural products COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 125000002541 furyl group Chemical group 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- 229940095102 methyl benzoate Drugs 0.000 claims 2
- 125000006727 (C1-C6) alkenyl group Chemical group 0.000 claims 1
- ZRZGFGPKMTUBOI-UHFFFAOYSA-N 2-amino-4-(4-fluorophenyl)-n-(1h-indazol-5-yl)-6-methyl-1,4-dihydropyrimidine-5-carboxamide Chemical compound N1=C(N)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C(F)C=C1 ZRZGFGPKMTUBOI-UHFFFAOYSA-N 0.000 claims 1
- WYHCBMHBRCUTRB-UHFFFAOYSA-N 3-[5-(1h-indazol-5-ylcarbamoyl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidin-4-yl]benzoic acid Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=CC(C(O)=O)=C1 WYHCBMHBRCUTRB-UHFFFAOYSA-N 0.000 claims 1
- IAJLFGXHHNOMDW-UHFFFAOYSA-N 3-benzyl-6-(4-fluorophenyl)-n-(1h-indazol-5-yl)-4-methyl-2-oxo-1,6-dihydropyrimidine-5-carboxamide Chemical compound CC1=C(C(=O)NC=2C=C3C=NNC3=CC=2)C(C=2C=CC(F)=CC=2)NC(=O)N1CC1=CC=CC=C1 IAJLFGXHHNOMDW-UHFFFAOYSA-N 0.000 claims 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 claims 1
- UWRAYOBUXZXUKE-UHFFFAOYSA-N 4-(1,3-benzodioxol-4-yl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=CC2=CC(NC(=O)C2=C(NC(=O)NC2C=2C=3OCOC=3C=CC=2)C)=C1 UWRAYOBUXZXUKE-UHFFFAOYSA-N 0.000 claims 1
- HOCWQVUNZAUIQW-UHFFFAOYSA-N 4-(1,3-benzodioxol-5-yl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=CC2=CC(NC(=O)C2=C(NC(=O)NC2C=2C=C3OCOC3=CC=2)C)=C1 HOCWQVUNZAUIQW-UHFFFAOYSA-N 0.000 claims 1
- KDUCIBONFZVABB-UHFFFAOYSA-N 4-(1,3-benzothiazol-2-yl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=CC2=CC(NC(=O)C2=C(NC(=O)NC2C=2SC3=CC=CC=C3N=2)C)=C1 KDUCIBONFZVABB-UHFFFAOYSA-N 0.000 claims 1
- GUHNKNQAOXTXQN-UHFFFAOYSA-N 4-(1-benzofuran-2-yl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=CC2=CC(NC(=O)C2=C(NC(=O)NC2C=2OC3=CC=CC=C3C=2)C)=C1 GUHNKNQAOXTXQN-UHFFFAOYSA-N 0.000 claims 1
- SMMDAUKFRAJTRK-UHFFFAOYSA-N 4-(1-benzothiophen-2-yl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=CC2=CC(NC(=O)C2=C(NC(=O)NC2C=2SC3=CC=CC=C3C=2)C)=C1 SMMDAUKFRAJTRK-UHFFFAOYSA-N 0.000 claims 1
- GSTIZTSTBSSNCC-UHFFFAOYSA-N 4-(2,2-diphenylethenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C=C(C=1C=CC=CC=1)C1=CC=CC=C1 GSTIZTSTBSSNCC-UHFFFAOYSA-N 0.000 claims 1
- BXGNHZZBUKULEU-UHFFFAOYSA-N 4-(2,3-dihydro-1,4-benzodioxin-6-yl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=CC2=CC(NC(=O)C2=C(NC(=O)NC2C=2C=C3OCCOC3=CC=2)C)=C1 BXGNHZZBUKULEU-UHFFFAOYSA-N 0.000 claims 1
- DTHHVWPUGFFNNW-UHFFFAOYSA-N 4-(2,4-difluorophenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C(F)C=C1F DTHHVWPUGFFNNW-UHFFFAOYSA-N 0.000 claims 1
- OHTUZZOCMWKINM-UHFFFAOYSA-N 4-(2,6-difluorophenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=C(F)C=CC=C1F OHTUZZOCMWKINM-UHFFFAOYSA-N 0.000 claims 1
- AVEDGCCFEOGVGA-UHFFFAOYSA-N 4-(2-chlorophenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=CC=C1Cl AVEDGCCFEOGVGA-UHFFFAOYSA-N 0.000 claims 1
- NONJJUKJZZGMCM-UHFFFAOYSA-N 4-(2-chloroquinolin-3-yl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=CC2=CC(NC(=O)C2=C(NC(=O)NC2C=2C(=NC3=CC=CC=C3C=2)Cl)C)=C1 NONJJUKJZZGMCM-UHFFFAOYSA-N 0.000 claims 1
- VVDLARFFZQVDKD-UHFFFAOYSA-N 4-(2-fluorophenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=CC=C1F VVDLARFFZQVDKD-UHFFFAOYSA-N 0.000 claims 1
- RUUNIOMLHMGMAM-UHFFFAOYSA-N 4-(2-hydroxy-4-methoxyphenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound OC1=CC(OC)=CC=C1C1C(C(=O)NC=2C=C3C=NNC3=CC=2)=C(C)NC(=O)N1 RUUNIOMLHMGMAM-UHFFFAOYSA-N 0.000 claims 1
- SECAFBMQKJTYFP-UHFFFAOYSA-N 4-(2h-chromen-3-yl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=CC2=CC(NC(=O)C2=C(NC(=O)NC2C=2COC3=CC=CC=C3C=2)C)=C1 SECAFBMQKJTYFP-UHFFFAOYSA-N 0.000 claims 1
- ILZDPPZKFLERTA-UHFFFAOYSA-N 4-(3,4-diethoxyphenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C(OCC)C(OCC)=CC=C1C1C(C(=O)NC=2C=C3C=NNC3=CC=2)=C(C)NC(=O)N1 ILZDPPZKFLERTA-UHFFFAOYSA-N 0.000 claims 1
- BYHLVBRHNYDQMW-UHFFFAOYSA-N 4-(3,4-difluorophenyl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxylic acid Chemical compound N1C(=O)NC(C)=C(C(O)=O)C1C1=CC=C(F)C(F)=C1 BYHLVBRHNYDQMW-UHFFFAOYSA-N 0.000 claims 1
- UXUBQCRXPASGDL-UHFFFAOYSA-N 4-(3,4-difluorophenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C(F)C(F)=C1 UXUBQCRXPASGDL-UHFFFAOYSA-N 0.000 claims 1
- YFNRWWHQAZMLEB-UHFFFAOYSA-N 4-(3,4-difluorophenyl)-n-[3-(4-fluoroanilino)-1h-indazol-5-yl]-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C(NC=4C=CC(F)=CC=4)=NNC3=CC=2)C1C1=CC=C(F)C(F)=C1 YFNRWWHQAZMLEB-UHFFFAOYSA-N 0.000 claims 1
- CKVSZZUYZWKVSF-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C(OC)C(OC)=CC=C1C1C(C(=O)NC=2C=C3C=NNC3=CC=2)=C(C)NC(=O)N1 CKVSZZUYZWKVSF-UHFFFAOYSA-N 0.000 claims 1
- QYJPBLIDLPMOLY-UHFFFAOYSA-N 4-(3,5-dibromophenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC(Br)=CC(Br)=C1 QYJPBLIDLPMOLY-UHFFFAOYSA-N 0.000 claims 1
- YOOJIJWZLORODW-UHFFFAOYSA-N 4-(3-aminophenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=CC(N)=C1 YOOJIJWZLORODW-UHFFFAOYSA-N 0.000 claims 1
- NBKFDQQXRCAJKL-UHFFFAOYSA-N 4-(3-bromo-4-fluorophenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C(F)C(Br)=C1 NBKFDQQXRCAJKL-UHFFFAOYSA-N 0.000 claims 1
- DNOFJVRWWPPNDJ-UHFFFAOYSA-N 4-(3-bromophenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=CC(Br)=C1 DNOFJVRWWPPNDJ-UHFFFAOYSA-N 0.000 claims 1
- FKAYINDOJIDVDH-UHFFFAOYSA-N 4-(3-chloro-4-fluorophenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C(F)C(Cl)=C1 FKAYINDOJIDVDH-UHFFFAOYSA-N 0.000 claims 1
- QJFHBSOYEIWXDM-UHFFFAOYSA-N 4-(3-chlorophenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=CC(Cl)=C1 QJFHBSOYEIWXDM-UHFFFAOYSA-N 0.000 claims 1
- OOALCMJXEHJHLS-UHFFFAOYSA-N 4-(3-cyano-4-fluorophenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C(F)C(C#N)=C1 OOALCMJXEHJHLS-UHFFFAOYSA-N 0.000 claims 1
- KSJVKIPUWJHQNL-UHFFFAOYSA-N 4-(3-cyanophenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=CC(C#N)=C1 KSJVKIPUWJHQNL-UHFFFAOYSA-N 0.000 claims 1
- IYUJOEHDRMLQGE-UHFFFAOYSA-N 4-(3-fluoro-4-methoxyphenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C(F)C(OC)=CC=C1C1C(C(=O)NC=2C=C3C=NNC3=CC=2)=C(C)NC(=O)N1 IYUJOEHDRMLQGE-UHFFFAOYSA-N 0.000 claims 1
- JFQBMZRXDXNOQW-UHFFFAOYSA-N 4-(3-hydroxy-4-methoxyphenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C(O)C(OC)=CC=C1C1C(C(=O)NC=2C=C3C=NNC3=CC=2)=C(C)NC(=O)N1 JFQBMZRXDXNOQW-UHFFFAOYSA-N 0.000 claims 1
- AXRZRKVKXZAULO-UHFFFAOYSA-N 4-(3-hydroxyphenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=CC(O)=C1 AXRZRKVKXZAULO-UHFFFAOYSA-N 0.000 claims 1
- WAZSZNQPAUATDJ-UHFFFAOYSA-N 4-(3-imidazol-1-ylphenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(C=1)=CC=CC=1N1C=CN=C1 WAZSZNQPAUATDJ-UHFFFAOYSA-N 0.000 claims 1
- AAMHSIWFDKXUMZ-UHFFFAOYSA-N 4-(4-acetamidophenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=CC(NC(=O)C)=CC=C1C1C(C(=O)NC=2C=C3C=NNC3=CC=2)=C(C)NC(=O)N1 AAMHSIWFDKXUMZ-UHFFFAOYSA-N 0.000 claims 1
- CBEOKSFOIUBPOJ-UHFFFAOYSA-N 4-(4-bromophenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C(Br)C=C1 CBEOKSFOIUBPOJ-UHFFFAOYSA-N 0.000 claims 1
- NCPQBDQHXISGFZ-UHFFFAOYSA-N 4-(4-carbamoylphenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C(C(N)=O)C=C1 NCPQBDQHXISGFZ-UHFFFAOYSA-N 0.000 claims 1
- YJJMMMPXUUTXQO-UHFFFAOYSA-N 4-(4-chloro-2-fluorophenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C(Cl)C=C1F YJJMMMPXUUTXQO-UHFFFAOYSA-N 0.000 claims 1
- HHUBHLZUJCZEHF-UHFFFAOYSA-N 4-(4-chloro-2-fluorophenyl)-n-[3-(3,5-difluoroanilino)-1h-indazol-5-yl]-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C(NC=4C=C(F)C=C(F)C=4)=NNC3=CC=2)C1C1=CC=C(Cl)C=C1F HHUBHLZUJCZEHF-UHFFFAOYSA-N 0.000 claims 1
- LFFLRGYZVKOWTR-UHFFFAOYSA-N 4-(4-chlorophenyl)-6-(1h-indazol-5-yl)-1,3,4,7-tetrahydropyrrolo[3,4-d]pyrimidine-2,5-dione Chemical compound C1=CC(Cl)=CC=C1C1C(C(=O)N(C2)C=3C=C4C=NNC4=CC=3)=C2NC(=O)N1 LFFLRGYZVKOWTR-UHFFFAOYSA-N 0.000 claims 1
- JJQGYFOALOWJOT-UHFFFAOYSA-N 4-(4-chlorophenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C(Cl)C=C1 JJQGYFOALOWJOT-UHFFFAOYSA-N 0.000 claims 1
- ZSMLVUOYSUEJMJ-UHFFFAOYSA-N 4-(4-cyanophenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C(C#N)C=C1 ZSMLVUOYSUEJMJ-UHFFFAOYSA-N 0.000 claims 1
- UAJZJYHSCDDVGF-UHFFFAOYSA-N 4-(4-fluoro-3-nitrophenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C(F)C([N+]([O-])=O)=C1 UAJZJYHSCDDVGF-UHFFFAOYSA-N 0.000 claims 1
- RNZYWDUEQHKAKP-UHFFFAOYSA-N 4-(4-fluorophenyl)-6-(1h-indazol-5-yl)-1,3,4,4a,7,7a-hexahydropyrrolo[3,4-d]pyrimidine-2,5-dione Chemical compound C1=CC(F)=CC=C1C1C2C(=O)N(C=3C=C4C=NNC4=CC=3)CC2NC(=O)N1 RNZYWDUEQHKAKP-UHFFFAOYSA-N 0.000 claims 1
- BMSWNBUEXKCYMK-UHFFFAOYSA-N 4-(4-fluorophenyl)-6-(furan-2-yl)-n-(1h-indazol-5-yl)-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=CC(F)=CC=C1C1C(C(=O)NC=2C=C3C=NNC3=CC=2)=C(C=2OC=CC=2)NC(=O)N1 BMSWNBUEXKCYMK-UHFFFAOYSA-N 0.000 claims 1
- LEAYPJKAZZLJQP-UHFFFAOYSA-N 4-(4-fluorophenyl)-n-(1h-indazol-5-yl)-1,3,6-trimethyl-2-oxo-4h-pyrimidine-5-carboxamide Chemical compound C=1C=C2NN=CC2=CC=1NC(=O)C1=C(C)N(C)C(=O)N(C)C1C1=CC=C(F)C=C1 LEAYPJKAZZLJQP-UHFFFAOYSA-N 0.000 claims 1
- SKVWNRQWUBCWGF-UHFFFAOYSA-N 4-(4-fluorophenyl)-n-(1h-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyrimidine-5-carboxamide Chemical compound C=1C=C2NN=CC2=CC=1NC(=O)C1=C(C)NC(C)=NC1C1=CC=C(F)C=C1 SKVWNRQWUBCWGF-UHFFFAOYSA-N 0.000 claims 1
- KYZSREXWIWGHAA-UHFFFAOYSA-N 4-(4-fluorophenyl)-n-(1h-indazol-5-yl)-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=CC(F)=CC=C1C1C(C(=O)NC=2C=C3C=NNC3=CC=2)=CNC(=O)N1 KYZSREXWIWGHAA-UHFFFAOYSA-N 0.000 claims 1
- HBMFQRVZYVXIRW-UHFFFAOYSA-N 4-(4-fluorophenyl)-n-(1h-indazol-5-yl)-2-oxo-6-propan-2-yl-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C(C)C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C(F)C=C1 HBMFQRVZYVXIRW-UHFFFAOYSA-N 0.000 claims 1
- HSXIWJPDOUWREV-UHFFFAOYSA-N 4-(4-fluorophenyl)-n-(1h-indazol-5-yl)-2-oxo-6-propyl-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(CCC)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C(F)C=C1 HSXIWJPDOUWREV-UHFFFAOYSA-N 0.000 claims 1
- UMSWYKUWSJMNJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)-n-(1h-indazol-5-yl)-3,6-dimethyl-2-oxo-1,4-dihydropyrimidine-5-carboxamide Chemical compound C=1C=C2NN=CC2=CC=1NC(=O)C1=C(C)NC(=O)N(C)C1C1=CC=C(F)C=C1 UMSWYKUWSJMNJZ-UHFFFAOYSA-N 0.000 claims 1
- BASFXSFMYYLFRN-UHFFFAOYSA-N 4-(4-fluorophenyl)-n-(1h-indazol-5-yl)-6-(methoxymethyl)-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(COC)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C(F)C=C1 BASFXSFMYYLFRN-UHFFFAOYSA-N 0.000 claims 1
- HEAIGWIZTYAQTC-UHFFFAOYSA-N 4-(4-fluorophenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C(F)C=C1 HEAIGWIZTYAQTC-UHFFFAOYSA-N 0.000 claims 1
- HXUUEEYFYHUCLO-UHFFFAOYSA-N 4-(4-fluorophenyl)-n-(1h-indazol-5-yl)-6-methyl-2-sulfanylidene-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=S)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C(F)C=C1 HXUUEEYFYHUCLO-UHFFFAOYSA-N 0.000 claims 1
- CJRRTLQVXVJYCI-UHFFFAOYSA-N 4-(4-fluorophenyl)-n-(1h-indazol-5-yl)-n,6-dimethyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C=1C=C2NN=CC2=CC=1N(C)C(=O)C1=C(C)NC(=O)NC1C1=CC=C(F)C=C1 CJRRTLQVXVJYCI-UHFFFAOYSA-N 0.000 claims 1
- ZQGBRTDUEGNIQH-UHFFFAOYSA-N 4-(4-fluorophenyl)-n-[3-(4-fluorophenyl)-1h-indazol-5-yl]-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C(C=4C=CC(F)=CC=4)=NNC3=CC=2)C1C1=CC=C(F)C=C1 ZQGBRTDUEGNIQH-UHFFFAOYSA-N 0.000 claims 1
- WUJGESQHDUSFPB-UHFFFAOYSA-N 4-(4-hydroxyphenyl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C(O)C=C1 WUJGESQHDUSFPB-UHFFFAOYSA-N 0.000 claims 1
- PXXQNUBDAXPJGN-UHFFFAOYSA-N 4-(5-chloro-1,3-benzodioxol-4-yl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=CC2=CC(NC(=O)C2=C(NC(=O)NC2C=2C(=CC=C3OCOC3=2)Cl)C)=C1 PXXQNUBDAXPJGN-UHFFFAOYSA-N 0.000 claims 1
- VALJQCVITQBTFT-UHFFFAOYSA-N 4-(5-chlorothiophen-2-yl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C(Cl)S1 VALJQCVITQBTFT-UHFFFAOYSA-N 0.000 claims 1
- MDLZENCZHPLGCC-UHFFFAOYSA-N 4-(8-hydroxyquinolin-2-yl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=CC2=CC(NC(=O)C2=C(NC(=O)NC2C=2N=C3C(O)=CC=CC3=CC=2)C)=C1 MDLZENCZHPLGCC-UHFFFAOYSA-N 0.000 claims 1
- JWLVLVICBCIRLN-UHFFFAOYSA-N 4-(9h-fluoren-2-yl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=CC2=CC(NC(=O)C2=C(NC(=O)NC2C=2C=C3C(C4=CC=CC=C4C3)=CC=2)C)=C1 JWLVLVICBCIRLN-UHFFFAOYSA-N 0.000 claims 1
- HQMQPFVZCQJKBI-UHFFFAOYSA-N 4-(cyclohexen-1-yl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CCCCC1 HQMQPFVZCQJKBI-UHFFFAOYSA-N 0.000 claims 1
- DODJWPWSKWSCKB-UHFFFAOYSA-N 4-(furan-3-yl)-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C=1C=COC=1 DODJWPWSKWSCKB-UHFFFAOYSA-N 0.000 claims 1
- IHMKFFCDYNAXMG-FNORWQNLSA-N 4-[(e)-2-(furan-2-yl)ethenyl]-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1\C=C\C1=CC=CO1 IHMKFFCDYNAXMG-FNORWQNLSA-N 0.000 claims 1
- XGYRAWOIUZTCFB-SXGWCWSVSA-N 4-[(z)-1-chloro-2-phenylethenyl]-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(\Cl)=C\C1=CC=CC=C1 XGYRAWOIUZTCFB-SXGWCWSVSA-N 0.000 claims 1
- OUOJJWIPBLRECM-UHFFFAOYSA-N 4-[2,3-difluoro-4-(trifluoromethyl)phenyl]-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C(C(F)(F)F)C(F)=C1F OUOJJWIPBLRECM-UHFFFAOYSA-N 0.000 claims 1
- CIUMXBVZSOWKIJ-UHFFFAOYSA-N 4-[2-(4-chlorophenyl)ethyl]-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1CCC1=CC=C(Cl)C=C1 CIUMXBVZSOWKIJ-UHFFFAOYSA-N 0.000 claims 1
- XRPNNDBVIIZFSG-UHFFFAOYSA-N 4-[2-fluoro-3-(trifluoromethyl)phenyl]-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=CC(C(F)(F)F)=C1F XRPNNDBVIIZFSG-UHFFFAOYSA-N 0.000 claims 1
- ZEMFSKYLNNWGJT-UHFFFAOYSA-N 4-[2-fluoro-4-(trifluoromethyl)phenyl]-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C(C(F)(F)F)C=C1F ZEMFSKYLNNWGJT-UHFFFAOYSA-N 0.000 claims 1
- XZLAHYDQKAEOSU-UHFFFAOYSA-N 4-[3-(2,4-difluorophenyl)phenyl]-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(C=1)=CC=CC=1C1=CC=C(F)C=C1F XZLAHYDQKAEOSU-UHFFFAOYSA-N 0.000 claims 1
- BRQVXDKCTBIGLV-UHFFFAOYSA-N 4-[3-(2-hydroxyethoxy)phenyl]-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=CC(OCCO)=C1 BRQVXDKCTBIGLV-UHFFFAOYSA-N 0.000 claims 1
- KHNYNVLWGJAKPF-UHFFFAOYSA-N 4-[3-(3-aminophenyl)phenyl]-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(C=1)=CC=CC=1C1=CC=CC(N)=C1 KHNYNVLWGJAKPF-UHFFFAOYSA-N 0.000 claims 1
- QYYVEHKZYYSTFQ-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-yl)phenyl]-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=CC2=CC(NC(=O)C2=C(NC(=O)NC2C=2C=CC(=CC=2)C=2C=C3OCOC3=CC=2)C)=C1 QYYVEHKZYYSTFQ-UHFFFAOYSA-N 0.000 claims 1
- VXTMCNVWHTXBBM-UHFFFAOYSA-N 4-[4-(2-chlorophenyl)phenyl]-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(C=C1)=CC=C1C1=CC=CC=C1Cl VXTMCNVWHTXBBM-UHFFFAOYSA-N 0.000 claims 1
- JQBLLMIGSHUQDV-UHFFFAOYSA-N 4-[4-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound CC1=NOC(C)=C1C1=CC=C(C2C(=C(C)NC(=O)N2)C(=O)NC=2C=C3C=NNC3=CC=2)C=C1 JQBLLMIGSHUQDV-UHFFFAOYSA-N 0.000 claims 1
- IIMHCKFZHXTTAL-UHFFFAOYSA-N 4-[4-(3-acetylphenyl)phenyl]-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound CC(=O)C1=CC=CC(C=2C=CC(=CC=2)C2C(=C(C)NC(=O)N2)C(=O)NC=2C=C3C=NNC3=CC=2)=C1 IIMHCKFZHXTTAL-UHFFFAOYSA-N 0.000 claims 1
- NWCCCUAPXCXHSU-UHFFFAOYSA-N 4-[4-(3-aminophenyl)phenyl]-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(C=C1)=CC=C1C1=CC=CC(N)=C1 NWCCCUAPXCXHSU-UHFFFAOYSA-N 0.000 claims 1
- YDUXGXLPNNPIAI-UHFFFAOYSA-N 4-[4-(3-chlorophenyl)phenyl]-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(C=C1)=CC=C1C1=CC=CC(Cl)=C1 YDUXGXLPNNPIAI-UHFFFAOYSA-N 0.000 claims 1
- DMDSRPNPDKALKX-UHFFFAOYSA-N 4-[4-(4-chlorophenyl)phenyl]-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(C=C1)=CC=C1C1=CC=C(Cl)C=C1 DMDSRPNPDKALKX-UHFFFAOYSA-N 0.000 claims 1
- VVYYTSDWLRJYQI-UHFFFAOYSA-N 4-[4-(benzimidazol-1-yl)phenyl]-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=CC2=CC(NC(=O)C2=C(NC(=O)NC2C=2C=CC(=CC=2)N2C3=CC=CC=C3N=C2)C)=C1 VVYYTSDWLRJYQI-UHFFFAOYSA-N 0.000 claims 1
- HIOJVXQQHYBGEQ-UHFFFAOYSA-N 4-[4-(diethylamino)phenyl]-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=CC(N(CC)CC)=CC=C1C1C(C(=O)NC=2C=C3C=NNC3=CC=2)=C(C)NC(=O)N1 HIOJVXQQHYBGEQ-UHFFFAOYSA-N 0.000 claims 1
- HPYPSWCUSVUVSO-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=CC(N(C)C)=CC=C1C1C(C(=O)NC=2C=C3C=NNC3=CC=2)=C(C)NC(=O)N1 HPYPSWCUSVUVSO-UHFFFAOYSA-N 0.000 claims 1
- DQTBIALKOUYFPZ-UHFFFAOYSA-N 4-[4-[3,5-bis(trifluoromethyl)phenyl]phenyl]-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(C=C1)=CC=C1C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 DQTBIALKOUYFPZ-UHFFFAOYSA-N 0.000 claims 1
- XJGHKGULSGVZCJ-UHFFFAOYSA-N 4-[5-(1h-indazol-5-ylcarbamoyl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidin-4-yl]benzoic acid Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C(C(O)=O)C=C1 XJGHKGULSGVZCJ-UHFFFAOYSA-N 0.000 claims 1
- VDDXLQMFWJRQIS-UHFFFAOYSA-N 4-[5-(4-chlorophenyl)furan-2-yl]-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(O1)=CC=C1C1=CC=C(Cl)C=C1 VDDXLQMFWJRQIS-UHFFFAOYSA-N 0.000 claims 1
- IMSPPFKAHVOUSG-UHFFFAOYSA-N 4-[5-(4-chlorophenyl)thiophen-2-yl]-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(S1)=CC=C1C1=CC=C(Cl)C=C1 IMSPPFKAHVOUSG-UHFFFAOYSA-N 0.000 claims 1
- XOGYYBLHTFRLGF-UHFFFAOYSA-N 4-imidazol-1-yl-n-(1h-indazol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1N1C=CN=C1 XOGYYBLHTFRLGF-UHFFFAOYSA-N 0.000 claims 1
- SGKHWSIVBXNPMI-UHFFFAOYSA-N 6-(4-fluorophenyl)-n-(1h-indazol-5-yl)-3,4-dimethyl-2-oxo-1,6-dihydropyrimidine-5-carboxamide Chemical compound C=1C=C2NN=CC2=CC=1NC(=O)C1=C(C)N(C)C(=O)NC1C1=CC=C(F)C=C1 SGKHWSIVBXNPMI-UHFFFAOYSA-N 0.000 claims 1
- LQVVJPZXVARYTO-UHFFFAOYSA-N 6-ethyl-4-(4-fluorophenyl)-n-(1h-indazol-5-yl)-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(CC)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C(F)C=C1 LQVVJPZXVARYTO-UHFFFAOYSA-N 0.000 claims 1
- 102000003989 Aurora kinases Human genes 0.000 claims 1
- 108090000433 Aurora kinases Proteins 0.000 claims 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 125000005725 cyclohexenylene group Chemical group 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims 1
- BGMKVCPDQPEXES-UHFFFAOYSA-N n-(1h-indazol-5-yl)-3,4-dimethyl-6-naphthalen-2-yl-2-oxo-1,6-dihydropyrimidine-5-carboxamide Chemical compound C1=CC=CC2=CC(C3NC(=O)N(C(=C3C(=O)NC=3C=C4C=NNC4=CC=3)C)C)=CC=C21 BGMKVCPDQPEXES-UHFFFAOYSA-N 0.000 claims 1
- KCMZXDIKMYTWQP-UHFFFAOYSA-N n-(1h-indazol-5-yl)-4,6-dimethyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound CC1NC(=O)NC(C)=C1C(=O)NC1=CC=C(NN=C2)C2=C1 KCMZXDIKMYTWQP-UHFFFAOYSA-N 0.000 claims 1
- VXWJNTBXGNCVCV-UHFFFAOYSA-N n-(1h-indazol-5-yl)-4-(2-methoxyphenyl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound COC1=CC=CC=C1C1C(C(=O)NC=2C=C3C=NNC3=CC=2)=C(C)NC(=O)N1 VXWJNTBXGNCVCV-UHFFFAOYSA-N 0.000 claims 1
- RKBSTTDFPIHGSZ-UHFFFAOYSA-N n-(1h-indazol-5-yl)-4-(3-methoxyphenyl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound COC1=CC=CC(C2C(=C(C)NC(=O)N2)C(=O)NC=2C=C3C=NNC3=CC=2)=C1 RKBSTTDFPIHGSZ-UHFFFAOYSA-N 0.000 claims 1
- RXLGCKPYHLBOKB-UHFFFAOYSA-N n-(1h-indazol-5-yl)-4-(7-methoxy-1,3-benzodioxol-5-yl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=CC2=CC(NC(=O)C2=C(C)NC(=O)NC2C=2C=C(C=3OCOC=3C=2)OC)=C1 RXLGCKPYHLBOKB-UHFFFAOYSA-N 0.000 claims 1
- NGFQDHSOABYZMO-VQHVLOKHSA-N n-(1h-indazol-5-yl)-4-[(e)-2-(2-methoxyphenyl)ethenyl]-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound COC1=CC=CC=C1\C=C\C1C(C(=O)NC=2C=C3C=NNC3=CC=2)=C(C)NC(=O)N1 NGFQDHSOABYZMO-VQHVLOKHSA-N 0.000 claims 1
- ISOJDYSOFQCWML-WEVVVXLNSA-N n-(1h-indazol-5-yl)-4-[(e)-2-(4-methoxyphenyl)ethenyl]-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=CC(OC)=CC=C1\C=C\C1C(C(=O)NC=2C=C3C=NNC3=CC=2)=C(C)NC(=O)N1 ISOJDYSOFQCWML-WEVVVXLNSA-N 0.000 claims 1
- KXVPRCVADDQENP-UHFFFAOYSA-N n-(1h-indazol-5-yl)-4-[3-(methanesulfonamido)phenyl]-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=CC(NS(C)(=O)=O)=C1 KXVPRCVADDQENP-UHFFFAOYSA-N 0.000 claims 1
- IRTOYRKBWWITHM-UHFFFAOYSA-N n-(1h-indazol-5-yl)-4-[4-(1h-indol-5-yl)phenyl]-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=CC2=CC(NC(=O)C2=C(NC(=O)NC2C=2C=CC(=CC=2)C=2C=C3C=CNC3=CC=2)C)=C1 IRTOYRKBWWITHM-UHFFFAOYSA-N 0.000 claims 1
- XYBLFRGOPVWDLJ-UHFFFAOYSA-N n-(1h-indazol-5-yl)-4-[4-(2-methoxyphenyl)phenyl]-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound COC1=CC=CC=C1C1=CC=C(C2C(=C(C)NC(=O)N2)C(=O)NC=2C=C3C=NNC3=CC=2)C=C1 XYBLFRGOPVWDLJ-UHFFFAOYSA-N 0.000 claims 1
- ZSCQIIMHTVXEOQ-UHFFFAOYSA-N n-(1h-indazol-5-yl)-4-[4-(3-methoxyphenyl)phenyl]-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound COC1=CC=CC(C=2C=CC(=CC=2)C2C(=C(C)NC(=O)N2)C(=O)NC=2C=C3C=NNC3=CC=2)=C1 ZSCQIIMHTVXEOQ-UHFFFAOYSA-N 0.000 claims 1
- YJMOKNAAKJBBBO-UHFFFAOYSA-N n-(1h-indazol-5-yl)-4-[4-(4-methoxyphenyl)phenyl]-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=CC(OC)=CC=C1C1=CC=C(C2C(=C(C)NC(=O)N2)C(=O)NC=2C=C3C=NNC3=CC=2)C=C1 YJMOKNAAKJBBBO-UHFFFAOYSA-N 0.000 claims 1
- XRKVBEOHDBGHAR-UHFFFAOYSA-N n-(1h-indazol-5-yl)-4-[5-(4-methoxyphenyl)thiophen-2-yl]-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=CC(OC)=CC=C1C1=CC=C(C2C(=C(C)NC(=O)N2)C(=O)NC=2C=C3C=NNC3=CC=2)S1 XRKVBEOHDBGHAR-UHFFFAOYSA-N 0.000 claims 1
- KAHASSCTELSLEO-UHFFFAOYSA-N n-(1h-indazol-5-yl)-4-naphthalen-2-yl-2-oxo-6-propyl-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=CC2=CC(NC(=O)C2=C(NC(=O)NC2C=2C=C3C=CC=CC3=CC=2)CCC)=C1 KAHASSCTELSLEO-UHFFFAOYSA-N 0.000 claims 1
- DJAXOXYDCQLLAI-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-(1,3-thiazol-2-yl)-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=NC=CS1 DJAXOXYDCQLLAI-UHFFFAOYSA-N 0.000 claims 1
- QJHGUEUWJJKAPU-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-(2-phenyl-1,3-thiazol-4-yl)-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(N=1)=CSC=1C1=CC=CC=C1 QJHGUEUWJJKAPU-UHFFFAOYSA-N 0.000 claims 1
- LTNRGLIZJQNNBT-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-(2-phenylethyl)-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1CCC1=CC=CC=C1 LTNRGLIZJQNNBT-UHFFFAOYSA-N 0.000 claims 1
- CMBKTAAENRPOMQ-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-(2-phenylethynyl)-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C#CC1=CC=CC=C1 CMBKTAAENRPOMQ-UHFFFAOYSA-N 0.000 claims 1
- SYPAHRBDOSJCFY-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-(3-phenoxyphenyl)-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(C=1)=CC=CC=1OC1=CC=CC=C1 SYPAHRBDOSJCFY-UHFFFAOYSA-N 0.000 claims 1
- YJBOFDRVFOVZKG-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-(3-phenylmethoxyphenyl)-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(C=1)=CC=CC=1OCC1=CC=CC=C1 YJBOFDRVFOVZKG-UHFFFAOYSA-N 0.000 claims 1
- JBJDLLGCUNXVGS-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-(3-phenylphenyl)-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(C=1)=CC=CC=1C1=CC=CC=C1 JBJDLLGCUNXVGS-UHFFFAOYSA-N 0.000 claims 1
- ZSFKNTXWQHBBIV-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-(4-phenoxyphenyl)-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(C=C1)=CC=C1OC1=CC=CC=C1 ZSFKNTXWQHBBIV-UHFFFAOYSA-N 0.000 claims 1
- IDECFMSWWHTMMR-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-(4-phenylphenyl)-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(C=C1)=CC=C1C1=CC=CC=C1 IDECFMSWWHTMMR-UHFFFAOYSA-N 0.000 claims 1
- LZOKWWHBPOOJOA-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-(4-pyrazol-1-ylphenyl)-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(C=C1)=CC=C1N1C=CC=N1 LZOKWWHBPOOJOA-UHFFFAOYSA-N 0.000 claims 1
- IBUWOYSWDNTXRI-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-(4-pyridin-2-ylphenyl)-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(C=C1)=CC=C1C1=CC=CC=N1 IBUWOYSWDNTXRI-UHFFFAOYSA-N 0.000 claims 1
- AUALISKWEUNTQC-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-(4-sulfamoylphenyl)-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C(S(N)(=O)=O)C=C1 AUALISKWEUNTQC-UHFFFAOYSA-N 0.000 claims 1
- DJDHADMQMRGDRX-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-(4-thiophen-2-ylphenyl)-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(C=C1)=CC=C1C1=CC=CS1 DJDHADMQMRGDRX-UHFFFAOYSA-N 0.000 claims 1
- QVKCGRVPCLDBPH-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-(5-phenylthiophen-2-yl)-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(S1)=CC=C1C1=CC=CC=C1 QVKCGRVPCLDBPH-UHFFFAOYSA-N 0.000 claims 1
- XREYCRFSEBGOEO-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-(5-pyridin-2-ylthiophen-2-yl)-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(S1)=CC=C1C1=CC=CC=N1 XREYCRFSEBGOEO-UHFFFAOYSA-N 0.000 claims 1
- FTKKCUAWLGXPKI-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-(phenylmethoxymethyl)-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1COCC1=CC=CC=C1 FTKKCUAWLGXPKI-UHFFFAOYSA-N 0.000 claims 1
- VWWAIOMNFMYMEQ-JLHYYAGUSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-[(e)-1-phenylprop-1-en-2-yl]-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(/C)=C/C1=CC=CC=C1 VWWAIOMNFMYMEQ-JLHYYAGUSA-N 0.000 claims 1
- BLAVCMCICALBCB-VQHVLOKHSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-[(e)-2-phenylethenyl]-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1\C=C\C1=CC=CC=C1 BLAVCMCICALBCB-VQHVLOKHSA-N 0.000 claims 1
- NRRYKYWRAGPPQE-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-[3-(trifluoromethoxy)phenyl]-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=CC(OC(F)(F)F)=C1 NRRYKYWRAGPPQE-UHFFFAOYSA-N 0.000 claims 1
- RCKHYQBDJQNZTE-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-[3-(trifluoromethyl)phenyl]-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=CC(C(F)(F)F)=C1 RCKHYQBDJQNZTE-UHFFFAOYSA-N 0.000 claims 1
- GLSIIGWJNVHZAP-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-[4-(1,2,4-triazol-1-yl)phenyl]-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(C=C1)=CC=C1N1C=NC=N1 GLSIIGWJNVHZAP-UHFFFAOYSA-N 0.000 claims 1
- VIXBNZNTRAMJGQ-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-[4-(1h-pyrazol-4-yl)phenyl]-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(C=C1)=CC=C1C=1C=NNC=1 VIXBNZNTRAMJGQ-UHFFFAOYSA-N 0.000 claims 1
- OGDWEPIWGFLETJ-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-[4-(2-phenylethynyl)thiophen-2-yl]-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(SC=1)=CC=1C#CC1=CC=CC=C1 OGDWEPIWGFLETJ-UHFFFAOYSA-N 0.000 claims 1
- BJBMPBQKTKXHHO-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C(C(F)(F)F)C=C1 BJBMPBQKTKXHHO-UHFFFAOYSA-N 0.000 claims 1
- RYYYDBRNFWHPDE-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-[4-[4-(trifluoromethyl)phenyl]phenyl]-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(C=C1)=CC=C1C1=CC=C(C(F)(F)F)C=C1 RYYYDBRNFWHPDE-UHFFFAOYSA-N 0.000 claims 1
- YQNGDPPMQSSJCN-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-[5-(2-phenylethynyl)thiophen-2-yl]-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(S1)=CC=C1C#CC1=CC=CC=C1 YQNGDPPMQSSJCN-UHFFFAOYSA-N 0.000 claims 1
- RIIGMEADPXMBJU-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(S1)=CC=C1C1=CC=C(C(F)(F)F)C=C1 RIIGMEADPXMBJU-UHFFFAOYSA-N 0.000 claims 1
- DVFHVQGXXDORKK-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-phenyl-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=CC=C1 DVFHVQGXXDORKK-UHFFFAOYSA-N 0.000 claims 1
- LSZAPWZUKNOMPK-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-pyridin-4-yl-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=NC=C1 LSZAPWZUKNOMPK-UHFFFAOYSA-N 0.000 claims 1
- OSWVZPYDSLCTOA-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-quinolin-2-yl-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=CC2=CC(NC(=O)C2=C(NC(=O)NC2C=2N=C3C=CC=CC3=CC=2)C)=C1 OSWVZPYDSLCTOA-UHFFFAOYSA-N 0.000 claims 1
- KEZTXQYHUXCZHV-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-quinolin-3-yl-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=CC2=CC(NC(=O)C2=C(NC(=O)NC2C=2C=C3C=CC=CC3=NC=2)C)=C1 KEZTXQYHUXCZHV-UHFFFAOYSA-N 0.000 claims 1
- FUHKFGVAVWSVNW-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-quinolin-5-yl-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=CC2=CC(NC(=O)C2=C(NC(=O)NC2C=2C3=CC=CN=C3C=CC=2)C)=C1 FUHKFGVAVWSVNW-UHFFFAOYSA-N 0.000 claims 1
- GCLTYILPOFJNKO-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-quinoxalin-6-yl-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=CC2=CC(NC(=O)C2=C(NC(=O)NC2C=2C=C3N=CC=NC3=CC=2)C)=C1 GCLTYILPOFJNKO-UHFFFAOYSA-N 0.000 claims 1
- VIURSTSOBBPQCM-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-oxo-4-thiophen-3-yl-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C=1C=CSC=1 VIURSTSOBBPQCM-UHFFFAOYSA-N 0.000 claims 1
- QGPNEKFSTHUAKN-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-2-sulfanylidene-4-thiophen-3-yl-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=S)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C=1C=CSC=1 QGPNEKFSTHUAKN-UHFFFAOYSA-N 0.000 claims 1
- UICVGLUMJMOINQ-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-4-(2-methylpropyl)-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound CC(C)CC1NC(=O)NC(C)=C1C(=O)NC1=CC=C(NN=C2)C2=C1 UICVGLUMJMOINQ-UHFFFAOYSA-N 0.000 claims 1
- LQXHANIGKQIWSZ-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-4-(3-methyl-1-benzothiophen-2-yl)-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=CC2=CC(NC(=O)C2=C(C)NC(=O)NC2C2=C(C3=CC=CC=C3S2)C)=C1 LQXHANIGKQIWSZ-UHFFFAOYSA-N 0.000 claims 1
- BKEWYXVPRSIGPY-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-4-(3-methylthiophen-2-yl)-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=CSC(C2C(=C(C)NC(=O)N2)C(=O)NC=2C=C3C=NNC3=CC=2)=C1C BKEWYXVPRSIGPY-UHFFFAOYSA-N 0.000 claims 1
- ADVRJVVFWFMOAC-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-4-(3-nitrophenyl)-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 ADVRJVVFWFMOAC-UHFFFAOYSA-N 0.000 claims 1
- IUYBKMYZGSEYNA-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-4-(4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=CC2=CC(NC(=O)C2=C(C)NC(=O)NC2C=2C=C3OCCN(C3=CC=2)C)=C1 IUYBKMYZGSEYNA-UHFFFAOYSA-N 0.000 claims 1
- XYAPUHYLIUXZAL-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-4-(4-methylsulfonylphenyl)-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C(S(C)(=O)=O)C=C1 XYAPUHYLIUXZAL-UHFFFAOYSA-N 0.000 claims 1
- RHPBNPSQVPFHIF-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-4-(4-morpholin-4-ylphenyl)-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(C=C1)=CC=C1N1CCOCC1 RHPBNPSQVPFHIF-UHFFFAOYSA-N 0.000 claims 1
- ACDFGNFWBXORSY-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-4-(4-nitrophenyl)-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C1=CC=C([N+]([O-])=O)C=C1 ACDFGNFWBXORSY-UHFFFAOYSA-N 0.000 claims 1
- IXEDUDRPUIKJQO-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-4-(5-methylfuran-2-yl)-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound O1C(C)=CC=C1C1C(C(=O)NC=2C=C3C=NNC3=CC=2)=C(C)NC(=O)N1 IXEDUDRPUIKJQO-UHFFFAOYSA-N 0.000 claims 1
- MIEMNOMFNFESRS-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-4-(5-methylsulfanylthiophen-2-yl)-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound S1C(SC)=CC=C1C1C(C(=O)NC=2C=C3C=NNC3=CC=2)=C(C)NC(=O)N1 MIEMNOMFNFESRS-UHFFFAOYSA-N 0.000 claims 1
- SLQYQKAFDODYLZ-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-4-(5-methylthiophen-2-yl)-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound S1C(C)=CC=C1C1C(C(=O)NC=2C=C3C=NNC3=CC=2)=C(C)NC(=O)N1 SLQYQKAFDODYLZ-UHFFFAOYSA-N 0.000 claims 1
- WEZZJNGUFOLYHG-SOFGYWHQSA-N n-(1h-indazol-5-yl)-6-methyl-4-[(e)-2-(2-nitrophenyl)ethenyl]-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1\C=C\C1=CC=CC=C1[N+]([O-])=O WEZZJNGUFOLYHG-SOFGYWHQSA-N 0.000 claims 1
- IZGMQRPDTGROBW-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-4-[5-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]thiophen-2-yl]-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=CC=2)C1C(S1)=CC=C1C=1C=C(C(F)(F)F)N(C)N=1 IZGMQRPDTGROBW-UHFFFAOYSA-N 0.000 claims 1
- MOLPAOUABFKOBM-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-4-naphthalen-1-yl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=CC2=CC(NC(=O)C2=C(NC(=O)NC2C=2C3=CC=CC=C3C=CC=2)C)=C1 MOLPAOUABFKOBM-UHFFFAOYSA-N 0.000 claims 1
- BGWIWNHRYSHQDX-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-4-naphthalen-2-yl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=CC2=CC(NC(=O)C2=C(NC(=O)NC2C=2C=C3C=CC=CC3=CC=2)C)=C1 BGWIWNHRYSHQDX-UHFFFAOYSA-N 0.000 claims 1
- QILDKOUKJADHOQ-UHFFFAOYSA-N n-(1h-indazol-5-yl)-6-methyl-4-naphthalen-2-yl-2-sulfanylidene-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=CC2=CC(NC(=O)C2=C(NC(=S)NC2C=2C=C3C=CC=CC3=CC=2)C)=C1 QILDKOUKJADHOQ-UHFFFAOYSA-N 0.000 claims 1
- HUGYPGOVMNNWNK-UHFFFAOYSA-N n-(3-bromo-2h-indazol-5-yl)-4-(4-fluorophenyl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C(Br)=NNC3=CC=2)C1C1=CC=C(F)C=C1 HUGYPGOVMNNWNK-UHFFFAOYSA-N 0.000 claims 1
- LGOTWMHIQPNRNZ-UHFFFAOYSA-N n-(3-bromo-2h-indazol-5-yl)-6-methyl-2-oxo-4-thiophen-3-yl-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C(Br)=NNC3=CC=2)C1C=1C=CSC=1 LGOTWMHIQPNRNZ-UHFFFAOYSA-N 0.000 claims 1
- WXHZPKMSRXQOAG-UHFFFAOYSA-N n-(3-bromo-2h-indazol-5-yl)-6-methyl-4-naphthalen-2-yl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=C(Br)C2=CC(NC(=O)C2=C(NC(=O)NC2C=2C=C3C=CC=CC3=CC=2)C)=C1 WXHZPKMSRXQOAG-UHFFFAOYSA-N 0.000 claims 1
- TUBXQMQXGWKLFD-UHFFFAOYSA-N n-(3-chloro-2h-indazol-5-yl)-4-(4-fluorophenyl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C(Cl)=NNC3=CC=2)C1C1=CC=C(F)C=C1 TUBXQMQXGWKLFD-UHFFFAOYSA-N 0.000 claims 1
- RDRNINVCHIGQHQ-UHFFFAOYSA-N n-(3-chloro-2h-indazol-5-yl)-6-methyl-4-naphthalen-2-yl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C1=C2NN=C(Cl)C2=CC(NC(=O)C2=C(NC(=O)NC2C=2C=C3C=CC=CC3=CC=2)C)=C1 RDRNINVCHIGQHQ-UHFFFAOYSA-N 0.000 claims 1
- NYMKLMOPVIINFF-UHFFFAOYSA-N n-(6-chloro-1h-indazol-5-yl)-6-methyl-4-naphthalen-2-yl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound C=1C=C2C=CC=CC2=CC=1C1NC(=O)NC(C)=C1C(=O)NC(C(=C1)Cl)=CC2=C1NN=C2 NYMKLMOPVIINFF-UHFFFAOYSA-N 0.000 claims 1
- UTCUKMMHEWXRIV-UHFFFAOYSA-N n-(6-fluoro-1h-indazol-5-yl)-4-(4-fluorophenyl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C(=CC=3NN=CC=3C=2)F)C1C1=CC=C(F)C=C1 UTCUKMMHEWXRIV-UHFFFAOYSA-N 0.000 claims 1
- FFJHNKDMDJAMRA-UHFFFAOYSA-N n-(7-chloro-1h-indazol-5-yl)-4-(4-fluorophenyl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C=NNC3=C(Cl)C=2)C1C1=CC=C(F)C=C1 FFJHNKDMDJAMRA-UHFFFAOYSA-N 0.000 claims 1
- LRNPBXHHMDJOIP-UHFFFAOYSA-N n-(7-chloro-1h-indazol-5-yl)-6-methyl-4-naphthalen-2-yl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound ClC1=C2NN=CC2=CC(NC(=O)C2=C(NC(=O)NC2C=2C=C3C=CC=CC3=CC=2)C)=C1 LRNPBXHHMDJOIP-UHFFFAOYSA-N 0.000 claims 1
- ZOTFTFUKLXZTLO-UHFFFAOYSA-N n-[3-(3,5-difluoroanilino)-1h-indazol-5-yl]-4-(3,4-difluorophenyl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C(NC=4C=C(F)C=C(F)C=4)=NNC3=CC=2)C1C1=CC=C(F)C(F)=C1 ZOTFTFUKLXZTLO-UHFFFAOYSA-N 0.000 claims 1
- RJKCBUGBEJUQIV-UHFFFAOYSA-N n-[3-(3,5-difluoroanilino)-1h-indazol-5-yl]-4-(3,5-difluorophenyl)-6-methyl-2-oxo-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C(NC=4C=C(F)C=C(F)C=4)=NNC3=CC=2)C1C1=CC(F)=CC(F)=C1 RJKCBUGBEJUQIV-UHFFFAOYSA-N 0.000 claims 1
- QBZFUFVYEVDYOT-UHFFFAOYSA-N n-[3-(3,5-difluoroanilino)-1h-indazol-5-yl]-6-methyl-2-oxo-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1h-pyrimidine-5-carboxamide Chemical compound N1C(=O)NC(C)=C(C(=O)NC=2C=C3C(NC=4C=C(F)C=C(F)C=4)=NNC3=CC=2)C1C1=CC=C(C(F)(F)F)C=C1 QBZFUFVYEVDYOT-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 0 *C(*)c1cc(cccc2)c2[s]1 Chemical compound *C(*)c1cc(cccc2)c2[s]1 0.000 description 4
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47975303P | 2003-06-19 | 2003-06-19 | |
| US60/479,753 | 2003-06-19 | ||
| PCT/US2004/019692 WO2004112719A2 (en) | 2003-06-19 | 2004-06-18 | Chemical compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007516173A JP2007516173A (ja) | 2007-06-21 |
| JP2007516173A5 true JP2007516173A5 (enExample) | 2007-08-02 |
| JP4869068B2 JP4869068B2 (ja) | 2012-02-01 |
Family
ID=33539215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006517466A Expired - Fee Related JP4869068B2 (ja) | 2003-06-19 | 2004-06-18 | 化合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7560467B2 (enExample) |
| EP (1) | EP1633740B1 (enExample) |
| JP (1) | JP4869068B2 (enExample) |
| AT (1) | ATE532781T1 (enExample) |
| ES (1) | ES2374272T3 (enExample) |
| WO (1) | WO2004112719A2 (enExample) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4857128B2 (ja) * | 2004-02-20 | 2012-01-18 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | 新規な化合物 |
| DE102004028862A1 (de) * | 2004-06-15 | 2005-12-29 | Merck Patent Gmbh | 3-Aminoindazole |
| JP2008503492A (ja) * | 2004-06-17 | 2008-02-07 | スミスクライン・ビーチャム・コーポレイション | Ｒｈｏ−キナーゼの新規阻害剤 |
| WO2006074293A2 (en) * | 2005-01-07 | 2006-07-13 | President And Fellows Of Harvard College | Bicyclic dihydropyrimidines as eg5 inhibitors |
| CN102633783A (zh) * | 2006-02-10 | 2012-08-15 | 转化技术制药公司 | 作为Aurora激酶抑制剂的苯并唑系衍生物、组合物和使用方法 |
| US20080153810A1 (en) * | 2006-11-15 | 2008-06-26 | Forest Laboratories Holdings Limited | Indazole derivatives useful as melanin concentrating receptor ligands |
| WO2008086404A1 (en) | 2007-01-10 | 2008-07-17 | Albany Molecular Research, Inc. | 5-pyridinone substituted indazoles |
| CN101861311A (zh) | 2007-07-21 | 2010-10-13 | 阿尔巴尼分子研究公司 | 5-吡啶酮取代的吲唑 |
| EP2459541A1 (en) * | 2009-07-30 | 2012-06-06 | F. Hoffmann-La Roche AG | Dihydropyrimidone amides as p2x7 modulators |
| US8846935B2 (en) | 2010-05-07 | 2014-09-30 | Glaxosmithkline Llc | Indazoles |
| MX2012012966A (es) | 2010-05-07 | 2013-01-22 | Glaxosmithkline Llc | Indoles. |
| EP2638149B1 (en) | 2010-11-12 | 2019-05-15 | Georgetown University | Immortalization of epithelial cells and methods of use |
| JO3363B1 (ar) | 2011-04-13 | 2019-03-13 | Epizyme Inc | مركبات بنزين مستبدلة بأريل أو أريل غير متجانس |
| US9174984B2 (en) | 2011-10-24 | 2015-11-03 | Glaxosmithkline Intellectual Property (No.2) Limited | Chemical compounds |
| AU2012332297B2 (en) | 2011-11-04 | 2016-01-07 | Glaxosmithkline Intellectual Property (No.2) Limited | Method of treatment |
| AU2013216935C1 (en) | 2012-02-08 | 2017-12-14 | John Emmerson Campbell | Heteroaryl compounds and methods of use thereof |
| BR112015008480A2 (pt) | 2012-10-15 | 2017-07-04 | Epizyme Inc | compostos de benzeno substituído |
| US9629851B2 (en) | 2013-09-20 | 2017-04-25 | Stitching Het Nederlands Kanker Institut—Antoni Van Leeuwenhoek Ziekenhuis | ROCK in combination with MAPK pathway |
| US20170233698A1 (en) | 2014-06-27 | 2017-08-17 | The Regents Of The University Of California | Cultured mammalian limbal stem cells, methods for generating the same, and uses thereof |
| US10023564B2 (en) | 2014-08-08 | 2018-07-17 | The Regents Of The University Of Michigan | G protein-coupled receptor kinase 2 inhibitors and methods for use of the same |
| CN107636149A (zh) | 2015-04-03 | 2018-01-26 | 普罗帕格尼克斯公司 | 上皮细胞的离体增殖 |
| US10100285B2 (en) | 2015-04-03 | 2018-10-16 | Propagenix Inc. | Ex vivo proliferation of epithelial cells |
| WO2016210403A1 (en) * | 2015-06-26 | 2016-12-29 | The Regents Of The University Of Michigan | G protein-coupled receptor kinase inhibitors and methods for use of the same |
| JP6869231B2 (ja) | 2015-09-11 | 2021-05-12 | プロパジェニクス インコーポレイテッド | ｅｘ ｖｉｖｏでの上皮細胞の増殖 |
| SG10202100724UA (en) | 2016-07-29 | 2021-03-30 | Sunovion Pharmaceuticals Inc | Compounds and compositions and uses thereof |
| BR112019001407A2 (pt) | 2016-07-29 | 2019-07-09 | Sunovion Pharmaceuticals Inc. | compostos e composições e usos dos mesmos |
| US11926596B2 (en) | 2017-07-21 | 2024-03-12 | Kadmon Corporation, Llc | Inhibitors of Rho associated coiled-coil containing protein kinase |
| MX2020000523A (es) | 2017-08-02 | 2020-08-20 | Sunovion Pharmaceuticals Inc | Compuestos de isocromano y usos de los mismos. |
| WO2020041065A1 (en) | 2018-08-20 | 2020-02-27 | Propagenix Inc. | Epithelial cell spheroids |
| CA3110661A1 (en) | 2018-08-29 | 2020-03-05 | University Of Massachusetts | Inhibition of protein kinases to treat friedreich ataxia |
| UY38427A (es) | 2018-10-26 | 2020-05-29 | Novartis Ag | Métodos y composiciones para terapia con células oculares |
| JP7703449B2 (ja) | 2019-03-14 | 2025-07-07 | スミトモ・ファーマ・アメリカ・インコーポレイテッド | イソクロマニル化合物の塩およびその結晶体、ならびにそれらの製造方法、治療用途および医薬組成物 |
| EP4010316A1 (en) * | 2019-08-08 | 2022-06-15 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd | Novel peripheral cannabinoid-1 receptor antagonists |
| US20230348852A1 (en) | 2020-04-27 | 2023-11-02 | Novartis Ag | Methods and compositions for ocular cell therapy |
| WO2022159688A1 (en) * | 2021-01-22 | 2022-07-28 | Cygnal Therapeutics, Inc. | Degraders of grk2 and uses thereof |
| KR20240099268A (ko) | 2021-10-18 | 2024-06-28 | 에비아 라이프 사이언시스 인코포레이션 | 간 섬유증 치료를 한 조성 및 사용 방법 |
| JP2024539220A (ja) | 2021-10-22 | 2024-10-28 | エヴィア ライフ サイエンシズ インコーポレイテッド | 細胞外小胞を作製するための方法、組成物、およびその使用方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE314362T1 (de) * | 1999-10-12 | 2006-01-15 | Takeda Pharmaceutical | Pyrimidin-5-carboximidverbindungen, verfahren zur herstellung derselben und deren verwendung |
| BR0116493A (pt) | 2000-12-21 | 2003-09-30 | Vertex Pharma | Compostos de pirazol úteis como inibidores de proteìna cinase |
| WO2002066443A2 (en) * | 2001-02-21 | 2002-08-29 | Ono Pharmaceutical Co., Ltd. | 2-thioxo-1,2,3,4-tetrahydropyrimidine derivatives |
| WO2002083648A1 (fr) * | 2001-04-16 | 2002-10-24 | Eisai Co., Ltd. | Nouveau compose a base de 1h-indazole |
| EP1403255A4 (en) | 2001-06-12 | 2005-04-06 | Sumitomo Pharma | RHO KINASE INHIBITORS |
| JP2008503492A (ja) * | 2004-06-17 | 2008-02-07 | スミスクライン・ビーチャム・コーポレイション | Ｒｈｏ−キナーゼの新規阻害剤 |
-
2004
- 2004-06-18 US US10/560,502 patent/US7560467B2/en not_active Expired - Fee Related
- 2004-06-18 JP JP2006517466A patent/JP4869068B2/ja not_active Expired - Fee Related
- 2004-06-18 AT AT04755699T patent/ATE532781T1/de active
- 2004-06-18 ES ES04755699T patent/ES2374272T3/es not_active Expired - Lifetime
- 2004-06-18 EP EP04755699A patent/EP1633740B1/en not_active Expired - Lifetime
- 2004-06-18 WO PCT/US2004/019692 patent/WO2004112719A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2543620C2 (ru) | Производные урацила или тимина для лечения гепатита с | |
| JP5040656B2 (ja) | トリアリールカルボン酸誘導体 | |
| CA2396824A1 (en) | Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2 | |
| JP2006503081A5 (enExample) | ||
| US6403633B2 (en) | Heteroaryl amidines, methylamidines and guanidines, and use thereof as protease inhibitors | |
| JP2009525960A5 (enExample) | ||
| JP2003529536A (ja) | Ｃ１ｓ介在疾患および状態の処置法、およびそれのための化合物および組成物 | |
| JP2020516671A5 (enExample) | ||
| HRP20170019T1 (hr) | Novi pirol-inhibitori od reduktaze s-nitrozoglutationa kao terapeutska sredstva | |
| JP2010513304A5 (enExample) | ||
| JP2006505522A5 (enExample) | ||
| CA2466490A1 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| JP2009525984A5 (enExample) | ||
| CA2454703A1 (en) | Novel thiophene carboxamide derivatives | |
| JP2016135778A (ja) | シアノトリアゾール化合物の医薬用途 | |
| JP2008513500A5 (enExample) | ||
| JP2007528887A5 (enExample) | ||
| JP2016525069A (ja) | シアノトリアゾール化合物 | |
| RU2009111113A (ru) | Мидуляторы mglur5 | |
| RU2007107349A (ru) | Пиперазиновые производные, применение для лечения желудочно-кишечных расстройств | |
| AU765072B2 (en) | Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors | |
| CA2553423A1 (en) | Heterocyclic compounds for use in the treatment of cancer and the inhibition of angiogenesis | |
| RU2007107177A (ru) | Соединения и композиции, как модуляторы ядерных рецепторов стероидных гормонов | |
| JP2010526106A5 (enExample) | ||
| JP2008526840A5 (enExample) |